Close Menu

Oops, Fake-Out

Merck published a journal containing reprinted or review articles that reported data favorable to the drug company, all without disclosing its sponsorship of the journal, says The Scientist. The journal, called the Australasian Journal of Bone and Joint Medicine, was published by a division of Elsevier, to which Merck paid an undisclosed sum, the article says. "To the jaundiced eye, [the journal] might be detected for what it is: marketing," Public Citizen's Peter Lurie says.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Bloomberg reports that the DNA-for-cash deal reported in Kentucky might be a more widespread scam.

St. Jude Children's Research Hospital scientists have treated infants with X-linked severe combined immunodeficiency using gene therapy in an early phase study.

St. Louis Public Radio reports that some African Americans are turning to DNA ancestry testing to help guide genealogical searches.

In Nature this week: a genomic analysis of the snailfish Pseudoliparis swirei, ancient DNA analysis gives insight into the introduction of farming to England, and more.